Le LV, Blach S, Rewari B, Chan P, Fuqiang C, Ishikawa N, Sharma M, Mangadan-Konath N, Razavi H, Low-Beer D, Razavi-Shearer D. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting. Liver Int. 2021 Dec 11. doi: 10.1111/liv.15131. Epub ahead of print. PMID: […]
Blach S, Blomé M, Duberg AS, Jerkeman A, Kåberg M, Klasa PE, Lagging M, Razavi-Shearer D, Razavi H, Aleman S. Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID-19. Liver Int. 2021 May 29:10.1111/liv.14978. doi: 10.1111/liv.14978. Epub ahead of print. PMID: 34051065; PMCID: PMC8242794. Summary Background & Aims […]
COVID-19 and global HCV elimination efforts. Sarah Blach, MHS, CPH. HCV Team Lead, CDA Foundation, Lafayette, CO, USA. EASL: International Liver Foundation. April 2020.
Gamkrelidze I, Pawlotsky JM, Lazarus JV, Feld JJ, Zeuzem S, Bao Y, Gabriela Pires Dos Santos A, Sanchez Gonzalez Y, Razavi H. Progress towards hepatitis C virus elimination in high-income countries: An updated analysis. Liver Int. 2021 Mar;41(3):456-463. doi: 10.1111/liv.14779. Epub 2021 Jan 19. PMID: 33389788. Summary Background & aims Elimination of HCV by 2030, […]
Razavi H. The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries. J Viral Hepat. 2021 Feb;28(2):445. doi: 10.1111/jvh.13442. Epub 2020 Dec 1. PMID: 33205589.
Polaris Observatory Collaborators. The case for simplifying and using absolute targets for viral hepatitis elimination goals. J Viral Hepat 2021;28:12–19. Summary The 69th World Health Assembly endorsed the Global Health Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as a public health threat by 2030. This was followed by the World […]
Dunn R, Musabaev E, Razavi H, Sadirova S, Bakieva S, Razavi-Shearer K, Brigida K, Kamili S, Averhoff F, Nasrullah M. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model – Tashkent, Uzbekistan, December 6, 2019-March 15, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 28;69(34):1161-1165. doi: 10.15585/mmwr.mm6934a3. PMID: 32853186; PMCID: PMC7451973. […]
Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, Gamkrelidze I, Ma S, Pawlotsky JM, Razavi-Shearer D, Razavi H, Waked I, Zeuzem S, Craxi A. Impact of COVID-19 on global HCV elimination efforts. J Hepatol. 2020 Aug 7:S0168-8278(20)30523-7. doi: 10.1016/j.jhep.2020.07.042. Epub ahead of print. PMID: 32777322; PMCID: PMC7411379. Summary Background & Aims […]
Palayew A, Razavi H, Hutchinson SJ, Cooke GS, Lazarus JV. Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C? Lancet Gastroenterol Hepatol. 2020 Oct;5(10):948-953. doi: 10.1016/S2468-1253(20)30011-X. Epub 2020 Jul 27. PMID: 32730784. Summary Do the most heavily burdened countries have the right policies to eliminate viral hepatitis […]
Kondili LA, Blach S, Razavi H, Craxì A. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination? Ann Ist Super Sanita. 2020 Jul-Sep;56(3):325-329. doi: 10.4415/ANN_20_03_10. PMID: 32959798. Summary Background and aims Hepatitis C virus (HCV) elimination for Italy is an ambitious, but […]